APP and Alzheimer disease: The concentrations of tTau and APP were reduced while the p-Tau-181/tTau ratio, Aβ42 level, Aβ42/Aβ40 ratio, and tTau/Aβ42 ratio were increased in plasma EVs, including exosomes, in the mild and moderate stages of AD [79].